Category Archives: Tms

Global Reflecting film Market Research Report provides key analysis on the market status of the Reflecting film with best facts and figures, meaning, definition, SWOT analysis, expert opinions, and the latest developments across the globe. The report also calculates the market size, Sales, Price, Revenue, Gross Margin, and Market Share, cost structure, and growth rate. The report considers the revenue generated from the sales of This Report and technologies by various application segments and Browse Market data Tables.

The Reflecting film Market report covers the different market scenarios that have a direct impact on the growth of the market. The Reflecting film report study includes information on market factors such as the market dynamics, including drivers, restraints, challenges, threats, and potential growth opportunities, market trends, development patterns, financial information, latest technologies, innovations, leading competitors, and regional analysis of the market.

RequestMore Information on this Report:https://www.worldwidemarketreports.com/sample/363600

Following Key Players are Mentioned in this Document:

NIPPA, TOYOBO, TMS, Mitsubishi, Esopp Group, Coating Innovation, Dowcorning, Brueckner

Analysis of Cardan ShaftMarket by Type

Metalized Films, Dielectric reflective film, Mixe

Analysis of Cardan ShaftMarket by Application

Exterior wall heat insulation, Chemical industries, Others

Get Sample to Understand More Details on Reflecting film Market Segments:https://www.worldwidemarketreports.com/sample/363600

Regional Analysis for Reflecting film Market:

North America (U.S., Canada)Europe (U.K., Italy, Germany, France, Rest of EU)Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)Latin America (Chile, Brazil, Argentina, Rest of Latin America)Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

(*NOTE: To get customization to your liking you can ADD / REMOVE Key Players, Regions, and any other Segments as you need.)

TO UNDERSTAND HOW COVID-19 IMPACT IS COVERED IN THIS REPORT

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Impact Reflecting film market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations, travel bans, and quarantines, restaurants closed, all indoor/outdoor events restricted, over forty countries state of emergency declared, massive slowing of the supply chain, stock market volatility, falling business confidence, growing panic among the population, and uncertainty about future.

In this segment, we will give you the impact of COVID-19, how it affected the Reflecting film market, and how it will change the industrys future depends on the current government, private, and public situations. Our expert analysts keep an open eye on every situation that may change the flow of the industry which will help you make the best possible decision for your enterprise.

The objective of the study is to define the Reflecting film market sizes of different segments and countries in previous years and to forecast the values for the next five years. The report is designed to incorporate both qualify qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about crucial aspects such as drivers and restraining factors that will define the future growth of the Reflecting film market.

You can Buy This Report Here:https://www.worldwidemarketreports.com/buy/363600

Report Coverage

Why Choose Reflecting film Market Report?

Contact Us:Worldwide Market Reports,Tel: U.S. +1-415-871-0703U.K. +44-203-289-4040Japan +81-50-5539-1737Email: [emailprotected]

Read more from the original source:

Profitable Strategic Report on Reflecting film Market With Included Analysis of New Trends, Updates, and Forecast to 2027: NIPPA, TOYOBO, TMS,...

Press release, Helsinki, 15 October 2021 at 9 AM (EEST)

Nexstims SmartFocus TMS Technology Used in Award-Winning Project Addressing Disorders of Consciousness after Severe Brain Injury

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that a research project utilizing the Companys SmartFocus TMS technology has been awarded the Human Brain Project (HBP) Innovation Award. Professor Marcello Massimini and his team from the Department of Clinical and Biomedical Sciences at University of Milan were given the award for their work on researching and developing a way to diagnose disorders of consciousness after brain injuries.

The project offers Nexstim and Nexstim users a great opportunity to appreciate the opportunities offered by the development of the unique SmartFocus TMS technology. For future development, Nexstim has delivered a system prototype to the University of Milan. The system was developed to better suit the purpose of measuring the internal complexity of the brain in patients that suffer from some level of unconsciousness following a severe brain injury.

Professor Marcello Massiminis interview on the research project can be found on the HBP website: https://www.humanbrainproject.eu/en/follow-hbp/news/2021/10/14/marcello-massimini-and-pci-team-have-been-selected-second-hbp-innovation-award/

Henri Hannula, Vice President, International Sales and Marketing at Nexstim, commented: The Human Brain Project Innovation Award is great recognition for Professor Marcello Massimini and his team for their pioneering work by using our unique SmartFocus TMS technology to test new ways to probe and diagnose the brain. These kind of reproducible clinical study results based on solid science are a great basis for the development of new clinical applications. This allows other teams to better connect with the brain non-invasively and do diagnostics when using the same tools and following the same protocols.

Story continues

Mikko Karvinen, CEO of Nexstim, commented: We congratulate Professor Marcello Massimini and his team for their great work and this accolade of the Human Brain Project Innovation Award. Their successful science work and this award highlights that Nexstims unique SmartFocus technology is enabling solid neuroscience, allowing us to further develop our product platform for many types of procedures related to brain diseases and disorders. This also shows the potential of our technology in exploring new business opportunities in the future.

Further information is available on the website http://www.nexstim.com, or by contacting:

Mikko Karvinen, CEO+358 50 326 4101mikko.karvinen@nexstim.com

About Nexstim Plc

Nexstim is a Finnish, globally operating medical technology company. Our mission is to enable personalized and effective therapies and diagnostics for challenging brain diseases and disorders.

Nexstim has developed a world-leading non-invasive brain stimulation technology called SmartFocus. It is a navigated transcranial magnetic stimulation (nTMS) technology with highly sophisticated 3D navigation providing accurate and personalized targeting of the TMS to the specific area of the brain.

SmartFocus technology is used in Nexstims proprietary Navigated Brain Therapy (NBT) system, which is FDA cleared for marketing and commercial distribution for the treatment of major depressive disorder (MDD) in the United States. In Europe, the NBT system is CE marked for the treatment of major depression and chronic neuropathic pain.

In addition, Nexstim is commercializing its SmartFocus based Navigated Brain Stimulation (NBS) system for diagnostic applications. The NBS system is the only FDA cleared and CE marked navigated TMS system for pre-surgical mapping of the speech and motor cortices of the brain. Nexstim shares are listed on the Nasdaq First North Growth Market Finland and Nasdaq First North Growth Market Sweden.

For more information please visit http://www.nexstim.com

Attachment

Originally posted here:

Nexstims SmartFocus TMS Technology Used in Award-Winning Project Addressing Disorders of Consciousness after Severe Brain Injury - Yahoo Finance

Is the Indian aviation sector showing clear signs of recovery? Is this the rebirth of the film industry after a pandemic pause? How are fuel-cell electric vehicles different from EVs? Get all answers

Topics Indian aviation|Electric Vehicles|Indian film industry

Team TMS | New Delhi Last Updated at October 14, 2021 15:51 IST

Indian airlines have seen a steady rise in passenger traffic in the past two months. And, just in time for the festival season, the government has allowed domestic flights to operate at 100% capacity. This, coupled with other announcements by the government, is supporting the revival of Indias civil aviation sector. What else is playing in the industrys favour. *** With more than 100 films slated for release over the next four months, Indias film industry is experiencing a rebirth of sorts after the pandemic affected its business. Producers are seeing this as an opportune time to release some of their big titles, which were postponed because of Covid-19. *** Wednesdays trading session clearly belonged to Tata Group stocks, with select stocks like Tata Motors, Tata Power zooming as much as 20% each on the back of the TPG investment in Tata Motors electric business unit.

What will be in the focus in todays trade?

Watch Video

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, October 14 2021. 09:05 IST

Go here to see the original:

TMS, Ep 20: Revival for aviation and cinemas, markets, and fuel-cell EVss - Business Standard

You are here:

05 October 2021

The benefits of Transcranial Magnetic Stimulation (TMS) on people with obsessive-compulsive disorder (OCD) is the focus of a collaborative study between Monash University and the Epworth Centre for Innovation in Mental Health (ECIMH).

OCD can have a profound effect on a persons life with psychological therapy, self-help techniques, and medication the current treatment options, although these are ineffective in many patients.Using a form of TMS, a non-invasive brain stimulation treatment that can change brain activity, researchers will use Theta-burst stimulation (TBS) to try to normalise brain activity in OCD patients.

The study offers participants individualised treatment using a process known as Neuronavigation, which involves mapping an individual's brain and then matching that to MRI images so that the treatment site can be found with more precision.

TMS has shown to be so successful for managing treatment-resistant depression that it has recently been added to the Medicare Benefits Schedule.

The study, being conducted at ECIMH is a collaboration between Professor Paul Fitzgerald from Monash University and Epworth Healthcare, Associate Professor Andrew Zalesky from the University of Melbourne, and Associate Professor Luca Cocchi from Research QIMR Berghofer, and is coordinated by Dr Oscar Murphy from the Monash Central Clinical School.

Dr Murphy says TMS is approved for the treatment of OCD by the US Food & Drug Administration. However, the same evidence base has not been established in Australia. This study will investigate the efficacy of TMS for OCD in Australia.

TMS is a very promising technology and has already shown efficacy in treating other conditions, such as depression, and is a promising step forward in developing individualised treatments, Dr Murphy said.

Involving a daily two to three-week treatment period with a three-month break in between, the trial is looking to recruit people aged between 18 and 75 until the end of 2021.

Given that many individuals with OCD may display fears of contamination or infection, the ongoing global pandemic has added a significant additional psychological burden for these individuals, with fewer people accessing treatments for OCD due to fears of going out in public, reduced capacity at clinics, longer waiting times to see clinicians due to the increased demand for mental health services and less social support.

Experiencing symptoms of OCD since early childhood, Rachel* was diagnosed in her early twenties. With her symptoms and fear of things being dirty, that people around her are going to be injured or die, and that things often feel out of place, increasing in intensity throughout her life, now in her sixties, she is often fearful to leave home and unable to work.

My compulsions relate to those obsessions, including rigid ordering and routine, excessive cleaning and counting rituals. Ive tried a plethora of typical pharmacological treatments for OCD but Ive been unable to tolerate medications well, often suffering debilitating nausea every time I try a new medication. The TMS trial is an alternative I just have to try - it gives me hope.

Dr Murphy says OCD is a severe and relatively common mental illness that significantly reduces the quality of life of more than 230,000 Australians, frequently leading to isolation, family dysfunction, difficulty in forming and maintaining relationships, and unemployment.

Although medications and other therapies are effective treatments for OCD, more than half of individuals with OCD still present with symptoms that affect their daily functioning more than 40 years after initial treatment. Many individuals also report experiencing side-effects of medications, which makes adherence to treatment quite difficult, he said.

The study we are running is particularly promising as we have identified regions of the brain that are typically altered in individuals with OCD and can then use MRI scans of the participants brain to identify where we will stimulate with TMS.

For more information on the trial or to register as a participant please click here.

*Pseudonyms have been used to protect the identity of the participant.She does not wish to be identified but is happy to talk to the media if her identity can remain anonymous.

Originally posted here:

New study to look at TMS treatment for OCD - Monash University

MURRIETA, Calif., Oct. 7, 2021 /PRNewswire/ --Inland Empire TMS is excited to announce the grand opening of its mental health treatment center in Murrieta, Riverside County.

Led by Dr. Keerthy Sunder, MD, an experienced physician, clinician, researcher, and teacher with an extensive background in mental health treatment, the center leverages state-of-the-art NeuroStar and MagVenture Transcranial Magnetic Stimulation (TMS)technology to treat patients who have not found success in standard psychotherapy and pharmaceutical interventions.

Dr. Sunder is a double-board certified psychiatrist and serves as the Chief Medical Officer of Karma Doctors & Associates, partnering with this new center to provide TMS therapy. This integrated approach to psychiatry represents an innovative form of treatment, underscoring Dr. Sunder's belief that true happiness and fulfillment for those struggling with depression is possible.

The Inland Empire TMS team of mental health professionals are passionate advocates for patients who have not had success in treating their depression through the more traditional avenues. TMS offers patients renewed hope for what life can hold after depression.

Unlike medications and other alternative options for treating depression, TMS is a non-invasive approach and has virtually no side effects. Patients engage in 40-minute sessions five days a week for six weeks. No anesthesia or mind-altering substances are used with this therapy, which means patients can independently drive themselves to and from the center for treatment.

TMS is unique because it is not an alternative therapy but rather a groundbreaking scientific approach to managing and/or eliminating depression. A large segment of this patient population achieves full remission from depression, which means that their symptoms disappear entirely.

TMS therapy gives patients hope that they can overcome treatment-resistant depression. Inland Empire TMS center represents an important role in helping those with depression to access an option for treatment that will net them the results they've been seeking.

To schedule a consultation or learn more about TMS and how Inland Empire TMS can help you, visit inlandempiretms.com.

Contact:Kyle Hartfield844-861-8886[emailprotected]

SOURCE Inland Empire TMS

The rest is here:

Inland Empire TMS Announces the Grand Opening of its TMS Center - PRNewswire

DUBLIN--(BUSINESS WIRE)--The "Roadway and Railway Tunnel Monitoring System (TMS) Market Report - Global Industry Data, Analysis and Growth Forecasts by Type, Application and Region, 2021-2028" report has been added to ResearchAndMarkets.com's offering.

Roadway and Railway Tunnel Monitoring System (TMS) market illustrates an attractive growth rate during the forecast period with the advancements in technologies. Latest developments in Artificial Intelligence and machine learning abilities to expand Roadway and Railway Tunnel Monitoring System (TMS) applications and drive demand during the forecast period to 2028.

The pandemic COVID 19 has a significant impact on the manufacturers of Roadway and Railway Tunnel Monitoring System (TMS) due to disruptions in the supply chain and frequent lockdowns. Further, the economic slowdown and geopolitical matters have limited the Roadway and Railway Tunnel Monitoring System (TMS) market growth in 2020. As the market recovers from the pandemic, we forecast the growth trajectory to vary across regions with some countries offering huge growth potential while others reporting limited profit margins.

New generation Roadway and Railway Tunnel Monitoring System (TMS) with improved performance offering higher accuracy and flexibility, with easy integration into systems spur the growth in Roadway and Railway Tunnel Monitoring System (TMS) industry. However, a paradigm shift towards a connected world and growing requirement for miniaturization are necessitating further advancement in the Roadway and Railway Tunnel Monitoring System (TMS) market and develop smarter products.

Research and development in the Roadway and Railway Tunnel Monitoring System (TMS) industry to drive down costs and improve functionality are expected to advance in the medium term. Autonomous vehicles poised to hit the mainstream alongside rapid growth in AI computing capabilities with improving commercials are offering enormous opportunities in the Roadway and Railway Tunnel Monitoring System (TMS) market. Over the forecast period to 2028, we forecast the Roadway and Railway Tunnel Monitoring System (TMS) market to regain growth momentum, mainly with support from developing markets.

Roadway and Railway Tunnel Monitoring System (TMS) market competitive landscape

On the Roadway and Railway Tunnel Monitoring System (TMS) market structure front, consolidation observed in 2020 is expected to be continued in 2021. Mergers and acquisitions are primarily intended to acquiring new technologies, strengthening portfolios, and leveraging capabilities.

Companies operating in the Roadway and Railway Tunnel Monitoring System (TMS) market were hard hit by the adverse effects of COVID, with the major difficulty being the supply chain management. Managing production with shortages in supply and man force has limited the profitability of companies in 2020 and created the need to adapt to more agile methods of working. However, growing trends of online work and education along with the exponential development of the e-commerce industry facilitate companies to regain their market share. Detailed profiles of top companies in the Roadway and Railway Tunnel Monitoring System (TMS) industry along with their key strategies to 2028 are provided in the report.

Reasons to Procure this Report

1. The report provides 2021 Roadway and Railway Tunnel Monitoring System (TMS) market revenues at the global, regional, and key country level with a detailed outlook to 2028 allowing companies to calculate their market share and analyze prospects, and uncover new markets to target

2. The research includes the Roadway and Railway Tunnel Monitoring System (TMS) market split by different types, technologies, applications, and end-uses. This segmentation helps managers plan their products and budgets based on future growth rates of each segment

3. The Roadway and Railway Tunnel Monitoring System (TMS) market study helps stakeholders understand the breadth and stance of the market giving them information on key drivers, restraints, challenges, and growth opportunities of the market and mitigate risks

4. This report would help top management understand competition better with a detailed SWOT analysis and key strategies of their competitors, and plan their position in the business

5. The study assists investors in analyzing Roadway and Railway Tunnel Monitoring System (TMS) business prospects by region, key countries, and top companies' information to channel their investments.

Key Topics Covered:

1. Executive Summary

2. Market Insights and Strategic Analysis

2.1 Key Market trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Industry Attractiveness - Porter's Five Forces Analysis

2.5 Impact of COVID-19 on the Market

3. Global Roadway and Railway Tunnel Monitoring System (TMS) Market Outlook

3.1 Global Roadway and Railway Tunnel Monitoring System (TMS) Market Outlook by Type, 2021-2028

3.2 Global Roadway and Railway Tunnel Monitoring System (TMS) Market Outlook by Application, 2021-2028

3.3 Global Roadway and Railway Tunnel Monitoring System (TMS) Market Outlook by Country, 2021-2028

4. Asia Pacific Roadway and Railway Tunnel Monitoring System (TMS) Market Outlook

5. Europe Roadway and Railway Tunnel Monitoring System (TMS) Market Outlook and Growth Opportunities

6. North America Roadway and Railway Tunnel Monitoring System (TMS) Market Outlook and Growth Opportunities

7. South and Central America Roadway and Railway Tunnel Monitoring System (TMS) Market Outlook and Growth Opportunities

8. Middle East Africa Roadway and Railway Tunnel Monitoring System (TMS) Market Outlook and Growth Opportunities

9. Competitive Analysis

10. Latest News and Developments in Global Roadway and Railway Tunnel Monitoring System (TMS) Market

11. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/2jh9vk

Link:

Global Roadway and Railway Tunnel Monitoring System Market Report to 2028 - by Type, Application and Region - ResearchAndMarkets.com - Business Wire

Y. Pritham Raj: 'As October is Depression Awareness Month, let's challenge ourselves to take a proactive approach.'

Amid COVID, another epidemic is on the horizon.

Mental health issues resulting from and exacerbated by COVID have created a second crisis. Between 2019 and 2020, the prevalence of depression increased fourfold. There are predictions that by 2035, depression will be the number-one cause of morbidity in the world.

As October is Depression Awareness Month, let's challenge ourselves to take a proactive approach.

One way is to look for the signs and symptoms of depression in yourself and others. There are many signs/symptoms of depression besides low mood. This includes sleeping more or less than usual, constant fatigue, restlessness, anxiety, irritability, poor appetite, unexplained weight gain or loss, and increased substance use. The actual diagnosis of major depression is made when symptoms persist for two weeks.

Isolation and taking care of kids or parents have taken their toll. This new way of living may prevent us from checking in with family, friends, and colleagues in our usual ways.

Burnout from stressful jobs can lead to depression. If you recognize these signs in yourself or someone you know, please reach out for help or advice. Your health insurance, a primary care doctor, a loved one, or NAMI (National Alliance on Mental Illness) helplines are all available resources.

It is essential to know that depression is treatable. Depending upon the type of depression, many people find relief through talk therapy and/or a course of antidepressants (that help correct how the brain uses neurotransmitters). Now there are even more options, like TMS (transcranial magnetic stimulation), which stimulates underactive brain areas related to mood. Most insurance plans cover these treatments.

Here are three ways to take care of our mental health:

Move your body. Physical activity is incredibly important for mental health! In one study, aerobic exercise had the same effect on mood as antidepressant medication. Just 30 minutes of walking or something similar each day will undoubtedly boost your mood and sense of wellbeing.

Reflect on the good. One of my favorite things to recommend is the "Three Good Things" exercise. At the end of each day, name three good things that happened to you. Go beyond simply thinking about what happened to you and consider your active part in it. I often do this with my kids at night. Research has shown that this simple practice helps build resiliency and prevents burnout.

Honor your passions. Our jobs and daily tasks don't always include activities that feel fulfilling. However, it's been proven that doing a little bit of what we're passionate about every week significantly impacts mental health and prevents burnout.

If you can, try to find a career you enjoy or focus on what you like about work. If that isn't possible, make efforts to do what you love outside of your job, whether it's volunteer work or a hobby.

It may be difficult to stay positive, but simple practices like these three can boost mood and wellbeing. Share these ideas with your loved ones, and let's combat burnout and depression together.

Y. Pritham Raj, M.D., is chief medical officer at Active Recovery TMS, a mental health clinic specializing in transcranial magnetic stimulation (TMS) as a treatment for depression and OCD. He is also an associate professor at Oregon Health & Science University in the departments of internal medicine and psychiatry.

You count on us to stay informed and we depend on you to fund our efforts.Quality local journalism takes time and money. Please support us to protect the future of community journalism.

Read the rest here:

OPINION: Burnout and depression are two sides of the same coin - Pamplin Media Group

TMS Entertainment will host "Women in Anime", a female-centric anime event, at the 17th Annual LA Femme International Film Festival that is FREE to the public and will run virtually from October 14th - 17th.

The segment will feature a powerhouse panel with women creators Minako Fujiyoshi (MEGALOBOX, MEGALOBOX 2: NOMAD) and Jinko Gotoh (Klaus, The Little Prince), followed by 2 episodes of the popular MEGALOBOX anime series sequel, MEGALOBOX 2: NOMAD.

Set seven years after the conclusion of the first season, MEGALOBOX 2: NOMAD continues the story of "Gearless" Joe, a former megalobox champion whose meteoric rise was told through the hit anime series MEGALOBOX. Now covered in scars and sporting his old gear, Joe reemerges from the shadows as "Nomad" returning to the ring to fight in the underground matches once again. The sequel series is currently available worldwide, exclusively on Funimation; Asian territories exempting

Minako Fujiyoshi is TMS Entertainment's first female producer. She made her debut as a producer with the MEGALOBOX project. Her previous experience involved working within the TMS production division, where she worked on numerous titles such as Hamtaro, the Anpanman Movies, Lupin the Third: The Woman Called Fujiko Mine and Sweetness and Lightning (original title: Amaama To Inazuma).

Jinko Gotoh is an Oscar-nominated producer and consultant for the animation industry. Her strengths and passion include the discovering and nurturing of diversified and creative talent and charting new technologies and creative processes. Jinko is currently producing her second animated feature for Netflix with Mark Osborne directing. Her other producing screen credits include: 2020 BAFTA winner and Oscar-nominated Klaus, The Lego Movie 2: The Second Part, The Little Prince, Oscar-nominated The Illusionist, 9, and Oscar-winning Finding Nemo. Jinko currently serves as vice president for Women in Animation. She is also on various committees for the Academy of Motion Pictures Arts and Sciences, and is the Co-Chair for Animation and VFX Committee for the Producers Guild of America.

Leslie LaPage from LA Femme states: "TMS Entertainment has been a great and supportive partner with LA Femme and their long-standing, creative anime series is a wonderful addition to the festival!"

LA Femme is offering this screening as a FREE event. LA Femme International Film Festival website: http://www.lafemme.org.

See original here:

WOMEN IN ANIME Event Announced At The 17th Annual LA Femme International Film Festival - Broadway World

In a report issued on October 1, Prasath Pandurangan from Bloom Burton maintained a Buy rating on Greenbrook Tms (GBNH Research Report), with a price target of $16.00. The companys shares closed last Monday at $7.26, close to its 52-week low of $7.10.

According to TipRanks.com, Pandurangan is a 1-star analyst with an average return of -0.5% and a 34.2% success rate. Pandurangan covers the Healthcare sector, focusing on stocks such as Aurinia Pharmaceuticals, Trillium Therapeutics, and Knight Therapeutics.

Currently, the analyst consensus on Greenbrook Tms is a Strong Buy with an average price target of $18.43, representing a 141.2% upside. In a report issued on September 23, Canaccord Genuity also maintained a Buy rating on the stock with a C$20.00 price target.

See todays analyst top recommended stocks >>

Based on Greenbrook Tms latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $13.71 million and GAAP net loss of $6.78 million. In comparison, last year the company earned revenue of $9.79 million and had a GAAP net loss of $9.48 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Greenbrook Tms, Inc. engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. It operates through Outpatient Mental Health Service Centers segment. The company was founded on February 9, 2018 and is headquartered in Toronto, Canada.

Read more from the original source:

Bloom Burton Thinks Greenbrook Tms Stock is Going to Recover - Analyst Ratings

The new study on the Global TMS Neuronavigation Systems Market 2021-2027 analyzes the crucial capabilities, key infrastructures, major organizations, evaluates measures to attain potential success in the TMS Neuronavigation Systems industry. Because of the in-depth overview of the world TMS Neuronavigation Systems market, the recent document allows investors, traders and manufacturers to plan some innovative techniques and meanwhile, align them with operational and commercial enterprise models. Additionally, the TMS Neuronavigation Systems market report provides crucial facets at the technological modifications that gained the TMS Neuronavigation Systems market, competitive environment, behavioral updates and so on.

In regards to explaining powerful insights of the global TMS Neuronavigation Systems market, the research report permits the investors and stakeholders to grab different techniques to extend distinct commercial patterns and practices. Besides this, the TMS Neuronavigation Systems market report offers important statistics about the worldwide TMS Neuronavigation Systems market such as opportunities, threats, main drivers, and key restraints of the TMS Neuronavigation Systems market in the period of the years 2021-2027.

Download a FREE Sample copy of the TMS Neuronavigation Systems Market Research: https://marketresearchexpertz.com/report/global-tms-neuronavigation-systems-market-313952#request-sample

The given report demonstrates an in-depth profiling of significant players alongside product portfolio, business operations, geographics dominance, financial status and specialized business operations. Apart from this, the value chain analysis of the global TMS Neuronavigation Systems market report has been merged with the competitive landscape of the prominent players of the TMS Neuronavigation Systems market. Reportedly, the TMS Neuronavigation Systems market size as well as forecast details of the TMS Neuronavigation Systems market for the predicted timespan from 2021 to 2027 has also been elaborated in this study. Detailed TMS Neuronavigation Systems market dynamics, and comprehensive evaluation by upstream as well as downstream raw materials have been discussed too.

The world TMS Neuronavigation Systems market report 2021 gives brief assessment on the TMS Neuronavigation Systems industry definition, essential driving factors, classification and systematic categorization on the basis of application, elite manufacturers, product types and important regions. The report on the TMS Neuronavigation Systems market has been fashioned through brief and exhaustive assessment of numerous parameters into consideration such as social, political, mechanical and ecological status of a particular geography. Moreover, it delivers noteworthy information along with futuristic estimations and elaborative analysis of the TMS Neuronavigation Systems market on a worldwide and regional level.

Outlook of COVID-19 Impact on TMS Neuronavigation Systems Industry:

Pivotal players operating in the TMS Neuronavigation Systems market are going through extremely dangerous conditions due to the COVID-19 pandemic, as they are witnessing a massive plunge in revenue contribution, lowest product demand, and reduction in growth probabilities. Although the coronavirus outbreak negatively affects the growth of the global TMS Neuronavigation Systems market, the industry is anticipated to recover by the upcoming months with the distribution of anti-Covid-19 vaccinations all over the world. Also we are offering 20% discount

If You Have a Any Query or Inquiry For Buying or Customization Report Click Here: https://marketresearchexpertz.com/report/global-tms-neuronavigation-systems-market-313952#inquiry-for-buying

TMS Neuronavigation Systems Market Segment classification as follows:

Leading Vendors of the TMS Neuronavigation Systems market report are:

Neurosoft (Russia)neuroCare Group (Germany)Inomed Medizintechnik (Germany)Rogue Resolutions (UK)MAG & More (Germany)Syneika (France)ANT Neuro (Netherlands)Soterix Medical (USA)Localite (Germany)Rogue Research (Canada)Soterix Medical (USA)SofTaxic Optic (Italy)

TMS Neuronavigation Systems market segments into Product Type:

PortableTrolley-mounted

Key Application of the TMS Neuronavigation Systems market report is:

HospitalClinic

Region-wise analysis of this report is given below:

North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia) Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

A holistic research of global TMS Neuronavigation Systems market is designed with the variety of things including insightful details, demographics conditions, competitive landscape, various other unique and important microeconomic as well as macroeconomic elements. It also discovers massive shift in the TMS Neuronavigation Systems market in accordance to aggressive gains and consequently the extensive rise in the working behavior of the leading industry vendors of the global TMS Neuronavigation Systems market.

Read Complete Analysis Report for Better Understanding: https://marketresearchexpertz.com/report/global-tms-neuronavigation-systems-market-313952

Key highlights of the Global TMS Neuronavigation Systems Market Report:

The TMS Neuronavigation Systems market findings demonstrate the client needs based on the respective locations. The report gives TMS Neuronavigation Systems market segmentation primarily based on completely distinct categories within the global TMS Neuronavigation Systems market. It offers the overview of the TMS Neuronavigation Systems market in phrases of annual sales, risk factors, TMS Neuronavigation Systems market share, major possibilities, manufacturing capacities and favourable prospects. The competitive landscape of the TMS Neuronavigation Systems market also analzyed in this report. The report delivers an intensified evaluation of the world TMS Neuronavigation Systems market, trendy developments as well as gain estimates during the expected years 2021 to 2027. Price adaptability of customers to services as well as products are evaluated in the global TMS Neuronavigation Systems market report. Distribution networks and essential operations are reported in the TMS Neuronavigation Systems market. Competitiveness of the major players each at countrywide & global level. With the help of tables, pie charts, figures and graphs assisting a proper inspection of the TMS Neuronavigation Systems market this study provides significant facts related to the worldwide TMS Neuronavigation Systems market.

Contact Us:

Market Research ExpertzEmail : sales@marketresearchexpertz.com Website : https://marketresearchexpertz.com/ Address : 3626 North Hall Street (Two Oak Lawn), Suite 610, Dallas, TX 75219 USA.

Continue reading here:

TMS Neuronavigation Systems Market (2021-2027) Growth Forecast At CAGR By Rogue Resolutions, MAG & More, Syneika, ANT Neuro - The Manomet Current